Literature DB >> 8127670

Regulation of adenovirus alternative RNA splicing at the level of commitment complex formation.

J P Kreivi1, G Akusjärvi.   

Abstract

The adenovirus late region 1 (L1) represents an example of an alternatively spliced gene where one 5' splice site is spliced to two alternative 3' splice sites, to produce two mRNAs; the 52,55K and IIIa mRNAs, respectively. Accumulation of the L1 mRNAs is temporally regulated during the infectious cycle. Thus, the proximal 3' splice site (52,55K mRNA) is used at all times during the infectious cycle whereas the distal 3' splice site (IIIa mRNA) is used exclusively late in infection. Here we show that in vitro splicing extracts prepared from late adenovirus-infected cells reproduces the virus-induced temporal shift from proximal to distal 3' splice site selection in L1 pre-mRNA splicing. Two stable intermediates in spliceosome assembly have been identified; the commitment complex and the pre-spliceosome (or A complex). We show that the transition in splice site activity in L1 alternative splicing results from an increase in the efficiency of commitment complex formation using the distal 3' splice site in extracts prepared from late virus-infected cells combined with a reduction of the efficiency of proximal 3' splice site splicing. The increase in commitment activity on the distal 3' splice site is paralleled by a virus-induced increase in A complex formation on the distal 3' splice site. Importantly, the virus-induced shift from proximal to distal L1 3' splice site usage does not require cis competition between the 52,55K and the IIIa 3' splice sites, but rather results from the intrinsic property of the two 3' splice sites which make them respond differently to factors in extracts prepared from virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8127670      PMCID: PMC523585          DOI: 10.1093/nar/22.3.332

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

2.  Sequences involved in the control of adenovirus L1 alternative RNA splicing.

Authors:  J P Kreivi; K Zerivitz; G Akusjärvi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway.

Authors:  S Michaud; R Reed
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

4.  Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project.

Authors:  P Senapathy; M B Shapiro; N L Harris
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 5.  Alternative splicing in the control of gene expression.

Authors:  C W Smith; J G Patton; B Nadal-Ginard
Journal:  Annu Rev Genet       Date:  1989       Impact factor: 16.830

6.  Mammalian U2 snRNP has a sequence-specific RNA-binding activity.

Authors:  K K Nelson; M R Green
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

7.  A compensatory base change in human U2 snRNA can suppress a branch site mutation.

Authors:  Y Zhuang; A M Weiner
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

8.  Mutations in yeast U5 snRNA alter the specificity of 5' splice-site cleavage.

Authors:  A Newman; C Norman
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

9.  Three protein factors (SF1, SF3 and U2AF) function in pre-splicing complex formation in addition to snRNPs.

Authors:  A Krämer; U Utans
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Biochemical characterization of U2 snRNP auxiliary factor: an essential pre-mRNA splicing factor with a novel intranuclear distribution.

Authors:  P D Zamore; M R Green
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  5 in total

1.  A novel type of splicing enhancer regulating adenovirus pre-mRNA splicing.

Authors:  O Mühlemann; B G Yue; S Petersen-Mahrt; G Akusjärvi
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Enhanced splicing of nonconsensus 3' splice sites late during adenovirus infection.

Authors:  O Mühlemann; J P Kreivi; G Akusjärvi
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.

Authors:  S K Petersen-Mahrt; C Estmer; C Ohrmalm; D A Matthews; W C Russell; G Akusjärvi
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

4.  RANBP2 and USP9x regulate nuclear import of adenovirus minor coat protein IIIa.

Authors:  Ashrafali M Ismail; Amrita Saha; Ji S Lee; David F Painter; Yinghua Chen; Gurdeep Singh; Gabriela N Condezo; James Chodosh; Carmen San Martín; Jaya Rajaiya
Journal:  PLoS Pathog       Date:  2022-06-16       Impact factor: 7.464

5.  U1 snRNP-ASF/SF2 interaction and 5' splice site recognition: characterization of required elements.

Authors:  S F Jamison; Z Pasman; J Wang; C Will; R Lührmann; J L Manley; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1995-08-25       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.